Attributable risk of Alzheimer's dementia attributed to age-related neuropathologies

Cited by (319)

Items 101–200 of 319

1. Value-Generating Exploratory Trials in Neurodegenerative Dementias
   Lauren G. Friedman, Nicholas McKeehan, Yuko Hara, Jeffrey L. Cummings, Dawn C. Matthews, Jian Zhu, Richard C. Mohs, Deli Wang, Suzanne B. Hendrix, Melanie Quintana et al. · 2021 · Neurology
2. Identification and validation of Alzheimer’s disease-related metabolic brain pattern in biomarker confirmed Alzheimer’s dementia patients
   Matej Perovnik, Petra Tomše, Jan Jamšek, Andreja Emeršič, Chris C. Tang, David Eidelberg, Maja Trošt · 2022 · Scientific Reports
3. Cognition, function, and prevalent dementia in centenarians and near‐centenarians: An individual participant data (IPD) meta‐analysis of 18 studies
   Yvonne Leung, Nir Barzilai, Agnieszka Batko‐Szwaczka, Nina Beker, Kathrin Boerner, Carol Brayne, Henry Brodaty, Siu Lan Karen Cheung, María M. Corrada, John D. Crawford et al. · 2022 · Alzheimer s & Dementia
4. Limbic-predominant age-related TDP-43 encephalopathy in the oldest old: a population-based study
   Elizaveta Mikhailenko, Kia Colangelo, Jarno Tuimala, Mia Kero, Sara Emilia Savola, Anna Raunio, Eloise Kok, Maarit Tanskanen, Mira Mäkelä, Henri A. J. Puttonen et al. · 2024 · Brain
5. Brain microRNAs are associated with variation in cognitive trajectory in advanced age
   Aliza P. Wingo, Mengli Wang, Jiaqi Liu, Michael S. Breen, Hyun‐Sik Yang, Beisha Tang, Julie A. Schneider, Nicholas T. Seyfried, James J. Lah, Allan I. Levey et al. · 2022 · Translational Psychiatry
6. Cognitive and Clinical Characteristics of Patients With Limbic-Predominant Age-Related TDP-43 Encephalopathy
   Rachel M Butler Pagnotti, Shehroo B. Pudumjee, Chad L. Cross, Justin B. Miller · 2023 · Neurology
7. Identifying individuals with non‐Alzheimer's disease co‐pathologies: A precision medicine approach to clinical trials in sporadic Alzheimer's disease
   Duygu Tosun, Ozlem Yardibi, Tammie L.S. Benzinger, Walter A. Kukull, Colin Louis Masters, Richard J. Perrin, Michael Walter Weiner, Arthur A. Simen, Adam James Schwarz, Alzheimer’s Disease Neuroimaging Initiative · 2023 · Alzheimer s & Dementia
8. Discovery of Proteoforms Associated With Alzheimer's Disease Through Quantitative Top-Down Proteomics
   James M. Fulcher, Ashley N. Ives, Shinya Tasaki, Shane S. Kelly, Sarah Williams, Thomas Fillmore, Mowei Zhou, Ronald Jay Moore, Weijun Qian, Ljiljana Paša‐Tolić et al. · 2025 · Molecular & Cellular Proteomics
9. Predementia constructs: Mild cognitive impairment or mild neurocognitive disorder? A narrative review
   Félix Bermejo‐Pareja, Israel Contador, Teodoro del Ser, Javier Olazarán, Sara Llamas Velasco, Saturio Vega, Julián Benito‐León · 2020 · International Journal of Geriatric Psychiatry
10. Multimodal Preventive Trial for Alzheimer's Disease: MIND-ADmini Pilot Trial Study Design and Progress
    Shireen Sindi, Charlotta Thunborg, Anna Rosenberg, P. Andersen, Sandrine Andrieu, Laus M. Broersen, Nicola Coley, C. Couderc, C.Z. Duval, Gerd Faxén Irving et al. · 2022 · The Journal of Prevention of Alzheimer s Disease
11. TDP ‐43 Pathology Exacerbates Cognitive Decline in Primary Age‐Related Tauopathy
    Denis S. Smirnov, David P. Salmon, Douglas R Galasko, Steven D. Edland, Donald P. Pizzo, Vanessa Goodwill, Annie OF Hiniker · 2022 · Annals of Neurology
12. Sex Moderates the Association between Frailty and Mild Behavioral Impairment
    Dylan X. Guan, Kenneth J. Rockwood, Eric Edward Smith, Zahinoor Ismail · 2022 · The Journal of Prevention of Alzheimer s Disease
13. Caffeine Consumption and Dementia: Are Lewy Bodies the Link?
    Marilyn C. Cornelis, David Alan Bennett, Sandra Weıntraub, Julie A. Schneider, Martha Clare Morris · 2022 · Annals of Neurology
14. Neuropathological associations of limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) differ between the oldest-old and younger-old
    Shih‐Hsiu J. Wang, Yuanyuan Guo, John F. Ervin, Jay B. Lusk, Sheng Luo · 2022 · Acta Neuropathologica
15. β-lactam antibiotics to tame down molecular pathways of Alzheimer's disease
    Shilpa Kumari, Rahul R Deshmukh · 2021 · European Journal of Pharmacology
16. Entorhinal Perfusion Predicts Future Memory Decline, Neurodegeneration, and White Matter Hyperintensity Progression in Older Adults
    Katherine J. Bangen, Alzheimer’s Disease Neuroimaging Initiative, Kelsey R. Thomas, Danielle L. Sanchez, Emily C. Edmonds, Alexandra J. Weigand, Lisa Delano‐Wood, Mark William Bondi · 2021 · Journal of Alzheimer s Disease
17. Resting EEG power spectra across middle to late life: associations with age, cognition, APOE-ɛ4 carriage, and cardiometabolic burden
    Ashleigh E. Smith, Anson C.M. Chau, Danielle Greaves, Hannah A. D. Keage, Daniel Feuerriegel · 2023 · Neurobiology of Aging
18. White matter fiber density abnormalities in cognitively normal adults at risk for late-onset Alzheimer's disease.
    S. Sánchez, B. Duarte-Abritta, C. Abulafia, G. De Pino, H. Bocaccio, M. Castro, G. Sevlever, G. Fonzo, C. Nemeroff, D. Gustafson et al. · 2020 · Journal of Psychiatric Research
19. Genetically Predicted Telomere Length and Its Relationship With Alzheimer’s Disease
    Guangping Yu, Leihong Lu, Zaihong Ma, Shouhai Wu · 2021 · Frontiers in Genetics
20. Changes in glial cell phenotypes precede overt neurofibrillary tangle formation, correlate with markers of cortical cell damage, and predict cognitive status of individuals at Braak III-IV stages
    Raquel N. Taddei, Maria Virtudes Sanchez-Mico, Orla Bonnar, Theresa R. Connors, Angelica Gaona, Dominique Denbow, Matthew P. Frosch, Teresa Gómez‐Isla · 2022 · Acta Neuropathologica Communications
21. Vascular and microstructural markers of cognitive pathology
    Claudia Ashlyn Coffin, Cynthia K. Suerken, James R. Bateman, Christopher T. Whitlow, Benjamin J. Williams, Mark Andrew Espeland, Bonnie C. Sachs, Maryjo L. Cleveland, Mia Yang, Samantha D. Rogers et al. · 2022 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
22. Are large simple trials for dementia prevention possible?
    William N. Whiteley, Sonia Savitri Anand, Shrikant I. Bangdiwala, Jackie Bosch, Michelle D. Canavan, Howard Mark Chertkow, Hertzel C. Gerstein, Philip B. Gorelick, Martin James O'Donnell, Guillaume Paré et al. · 2019 · Age and Ageing
23. A neurodegeneration checkpoint mediated by REST protects against the onset of Alzheimer’s disease
    Liviu Aron, Chenxi Qiu, Zhen‐Kai Ngian, Marianna Liang, Derek Drake, Jaejoon Choi, Marty A. Fernandez, Perle Roche, Emma L. Bunting, Ella K. Lacey et al. · 2023 · Nature Communications
24. Sex Differences in the Severity and Progression of Neuropsychiatric Symptoms Across Different Dementia Types
    Chiara Silvestri, Valentina Almici, Ilenia Libri, Irene Mattioli, Maura Cosseddu, Rosanna Turrone, Jasmine Rivolta, Chiara Grassini, Salvatore Caratozzolo, Antonella Alberici et al. · 2024 · Neurology Clinical Practice
25. Generalizability of trial criteria on amyloid-lowering therapy against Alzheimer’s disease to individuals with mild cognitive impairment or early Alzheimer’s disease in the general population
    Jacqueline Josephine Claus, Ilse vom Hofe, Annekee van Ijlzinga Veenstra, Silvan Licher, Harro Seelaar, Frank Jan de Jong, Julia Neitzel, Meike Willemijn Vernooij, M. Arfan Ikram, Frank J. Wolters · 2025 · European Journal of Epidemiology
26. Cybercrime against senior citizens: exploring ageism, ideal victimhood, and the pivotal role of socioeconomics
    Suleman Ibrahim Lazarus, Peter Tickner, Michael R. McGuire · 2025 · Security Journal
27. Brain Aging, Cardiovascular Diseases, Mixed Dementia, and Frailty in the Oldest Old: From Brain Phenotype to Clinical Expression
    Gianmarco Rosa, Chiara Giannotti, Lucia Anna Martella, Federico Massa, Gianluca Serafini, Matteo Pardini, Flavio Mariano Nobili, Fiammetta Monacelli · 2020 · Journal of Alzheimer s Disease
28. Mechanisms Underlying Non-Pharmacological Dementia Prevention Strategies: A Translational Perspective
    Vilma Alanko, Chinedu Theresa Udeh‐Momoh, Miia Kivipelto, Anna Matton · 2022 · The Journal of Prevention of Alzheimer s Disease
29. Human Brain and Blood N-Glycome Profiling in Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias
    Lei Yu, Zhiguang Huo, Jingyun Yang, Helena Palma‐Gudiel, Patricia A. Boyle, Julie A. Schneider, David Alan Bennett, Jinying Zhao · 2021 · Frontiers in Aging Neuroscience
30. Aducanumab and the “post-amyloid” era of Alzheimer research?
    Erik S. Musiek, David Alan Bennett · 2021 · Neuron
31. Neuropathologic Correlates of Human Cortical Proteins in Alzheimer Disease and Related Dementias
    Lei Yu, Patricia A. Boyle, Aliza P. Wingo, Jingyun Yang, Tianhao Wang, Aron S. Buchman, Thomas S. Wingo, Nicholas T. Seyfried, Allan I. Levey, Philip L. De Jager et al. · 2021 · Neurology
32. Alzheimer's disease‐associated CD83(+) microglia are linked with increased immunoglobulin G4 and human cytomegalovirus in the gut, vagal nerve, and brain
    Ben Readhead, Diego Mastroeni, Qi Wang, Maria A. Sierra, Camila de Ávila, Tajudeen O. Jimoh, Jean‐Vianney Haure‐Mirande, Kristina E. Atanasoff, Jennifer Nolz, Crystal Suazo et al. · 2024 · Alzheimer s & Dementia
33. Validating the Amyloid Cascade Through the Revised Criteria of Alzheimer's Association Workgroup 2024 for Alzheimer Disease
    Augusto J. Mendes, Federica Ribaldi, Michela Pievani, Cecilia Boccalini, Valentina Garibotto, Giovanni Battista Frisoni, Alzheimer’s Disease Neuroimaging Initiative · 2025 · Neurology
34. Herpes zoster vaccination and incident dementia in Canada: an analysis of natural experiments
    Michael Pomirchy, Seunghun Chung, Christian Bommer, Stephenson B. Strobel, Pascal Geldsetzer · 2026 · The Lancet Neurology
35. Assessment of Alzheimer-related pathologies of dementia using machine learning feature selection
    Mohammed Abdulrazzaq Rajab, Emmanuel Jammeh, Teruka Taketa, Carol Brayne, Fiona E. Matthews, Li Su, Paul G. Ince, Stephen B. Wharton, Dennis Y.Q. Wang, on behalf of the Cognitive Function and Ageing Neuropathology Study Group · 2023 · Alzheimer s Research & Therapy
36. A Step Forward in the Fight Against Dementia—Are We There Yet?
    David A. Wolk, Gil Dan Rabinovici, Bradford Clark Dickerson · 2023 · JAMA Neurology
37. The Key Factors Predicting Dementia in Individuals With Alzheimer’s Disease-Type Pathology
    Andrew N. McCorkindale, Ellis Patrick, James A. Duce, Boris Guennewig, Greg Trevor Sutherland · 2022 · Frontiers in Aging Neuroscience
38. Disentangling tau and brain atrophy cluster heterogeneity across the Alzheimer's disease continuum
    Jon B. Toledo, Hangfan Liu, Michel J. Grothe, Tanweer Rashid, Lenore J. Launer, Leslie M. J. Shaw, Haykel Snoussi, Susan R. Heckbert, Michael Walter Weiner, John Q. Trojanwoski et al. · 2022 · Alzheimer s & Dementia Translational Research & Clinical Interventions
39. Arterial Changes Connecting Hypertension to Alzheimer’s Disease and Related Dementias
    Gregory L. Burke, Timothy M. Hughes · 2021 · JACC. Cardiovascular imaging
40. Molecular hallmarks of excitatory and inhibitory neuronal resilience to Alzheimer’s disease
    Isabel Castanho, Pourya Naderi Yeganeh, Carles A. Boix, Sarah L. Morgan, Hansruedi Mathys, Dmitry Prokopenko, Bartholomew White, Larisa M. Soto, Giulia Pegoraro, Saloni A. Shah et al. · 2025 · Molecular Neurodegeneration
41. Structural variants linked to Alzheimer’s disease and other common age-related clinical and neuropathologic traits
    Ricardo A. Vialle, Kátia de Paiva Lopes, Yan Li, Bernard Ng, Julie A. Schneider, Aron S. Buchman, Yanling Wang, José M. Farfel, Lisa Laverne Barnes, Aliza P. Wingo et al. · 2025 · Genome Medicine
42. Integrative brain omics approach highlights sn-1 lysophosphatidylethanolamine in Alzheimer’s dementia
    Chih‐Yu Chen, Kristal M. Maner-Smith, Manoj Khadka, Jun Young Ahn, Xueyun Liu Gulbin, Anna Ivanova, Eric B. Dammer, Nicholas T. Seyfried, David Alan Bennett, Ihab M. Hajjar et al. · 2025 · Nature Communications
43. Targeting caspase-2 interactions with tau in Alzheimer's disease and related dementias
    Steffen Pockes, Michael A. Walters, Karen H. Ashe · 2022 · Translational research
44. Paradigm Shift: Multiple Potential Pathways to Neurodegenerative Dementia
    Amalia Perna, Kathleen S. Montine, Lon R. White, Thomas Jude Montine, Brenna Cholerton · 2023 · Neurotherapeutics
45. Vascular Contributions to Neurodegeneration: Protocol of the COMPASS-ND Study
    Eric Edward Smith, Simon Duchesne, Fuqiang Gao, Feryal Saad, Victor Whitehead, Cheryl R. McCreary, Richard Frayne, Serge G. Gauthier, Richard M. Camicioli, MICHAEL J. BORRIE et al. · 2021 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
46. The Clinician's Interview‐Based Impression of Change (Plus caregiver input) and goal attainment in two dementia drug trials: Clinical meaningfulness and the initial treatment response
    Justin Stanley, Susan Ellen Howlett, Taylor Dunn, Kenneth J. Rockwood · 2021 · Alzheimer s & Dementia
47. Predictors for Favorable Cognitive Outcome Post-Stroke: A-Seven-Year Follow-Up Study
    Guri Hagberg, Brynjar Fure, Bente Thommessen, Håkon Ihle‐Hansen, Anne‐Rita Öksengård, Ståle Nygård, Sarah Tamsin Pendlebury, Mona Kristiansen Beyer, Torgeir Bruun Wyller, Hege Ihle‐Hansen · 2019 · Dementia and Geriatric Cognitive Disorders
48. Developing robust biomarkers for vascular cognitive disorders: adding ‘V’ to the AT(N) research framework
    Sachdev, Perminder S. · 2020 · Current Opinion in Psychiatry
49. Accelerated brain ageing during the COVID-19 pandemic
    Ali‐Reza Mohammadi‐Nejad, Martin Craig, Eleanor F. Cox, Xin Chen, Gisli R. Jenkins, Susan Francis, Stamatios N. Sotiropoulos, Dorothee P. Auer · 2025 · Nature Communications
50. Vesicular Glutamate Transporter Changes in the Cortical Default Mode Network During the Clinical and Pathological Progression of Alzheimer’s Disease
    Zhiping Mi, Eric E. Abrahamson, Angela Y. Ryu, Michael H. Malek‐Ahmadi, Julia Kofler, Kenneth N. Fish, Robert A. Sweet, Victor L. Villemagne, Julie A. Schneider, Elliott Jay Mufson et al. · 2023 · Journal of Alzheimer s Disease
51. Neuropathologic Changes of Alzheimer’s Disease and Related Dementias: Relevance to Future Prevention
    Lon R. White, María M. Corrada, Claudia H. Kawas, Brenna Cholerton, Steve E. Edland, Margaret E. Flanagan, Thomas Jude Montine · 2023 · Journal of Alzheimer s Disease
52. The Venular Side of Cerebral Amyloid Angiopathy: Proof of Concept of a Neglected Issue
    Marialuisa Zedde, Ilaria Grisendi, Federica Assenza, Gabriele Vandelli, Manuela Napoli, Claudio Moratti, Piergiorgio Lochner, David Julian Seiffge, Fabrizio Piazza, Franco Valzania et al. · 2023 · Biomedicines
53. Pure LATE-NC: Frequency, clinical impact, and the importance of considering APOE genotype when assessing this and other subtypes of non-Alzheimer’s pathologies
    Yuriko Katsumata, Xian Wu, Khine Zin Aung, David W. Fardo, Davis C. Woodworth, S. Ahmad Sajjadi, Sandra O. Tomé, Dietmar Rudolf Thal, Juan Carlos Troncoso, Koping Chang et al. · 2024 · Acta Neuropathologica
54. WBQ5187, a Multitarget Directed Agent, Ameliorates Cognitive Impairment in a Transgenic Mouse Model of Alzheimer’s Disease and Modulates Cerebral β-Amyloid, Gliosis, cAMP Levels, and Neurodegeneration
    Zhiren Wang, Mengru Cao, Hongling Xiang, Wei Wang, Xing Feng, Xiaoping Yang · 2019 · ACS Chemical Neuroscience
55. CCCDTD5: Reducing the risk of later‐life dementia. Evidence informing the Fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD‐5)
    Kenneth J. Rockwood, Melissa Kathryn Andrew, Mylène Aubertin‐Leheudre, Sylvie Belleville, Louis Bherer, Susan K. Bowles, Dustin Scott Kehler, Andrew S. P. Lim, Laura Elizabeth Middleton, Natalie A. Phillips et al. · 2020 · Alzheimer s & Dementia Translational Research & Clinical Interventions
56. Discordance and Concordance Between Cerebrospinal and [ 18 F]FDG-PET Biomarkers in Assessing Atypical and Early-Onset AD Dementia Cases
    Kely Monica Quispialaya, Joseph Therriault, Antonio Aliaga, Maria Zimmermann, Jaime Fernández Arias, Firoza Zubeida Lussier, Gassan Massarweh, Tharick Ali Pascoal, Jean‐Paul Soucy, Serge G. Gauthier et al. · 2022 · Neurology
57. Intracranial atherosclerotic disease and neurodegeneration: a narrative review and plausible mechanisms
    Dixon Yang, Laurel J. Cherian, Konstantinos Arfanakis, Julie A. Schneider, Neelum T. Aggarwal, José Gutierrez · 2024 · Journal of Stroke and Cerebrovascular Diseases
58. The impact of arteriolosclerosis on cognitive impairment in decedents without severe dementia from the National Alzheimer's Coordinating Center
    Cellas A. Hayes, Christina B. Young, Carla Abdelnour Ruiz, Alexis N. Reeves, Michelle C. Odden, Jeffrey Nirschl, Paul K. Crane, Kathleen L. Poston, Elizabeth C. Mormino, Kyan Younes · 2025 · Alzheimer s & Dementia
59. Late-Life Vascular Risk Score in Association With Postmortem Cerebrovascular Disease Brain Pathologies
    Shahram Oveisgharan, Lei Yu, Ana Werneck Capuano, Zoe Arvanitakis, Lisa Laverne Barnes, Julie A. Schneider, David Alan Bennett, Aron S. Buchman · 2021 · Stroke
60. Exosomal Non-Coding RNAs as Potential Biomarkers for Alzheimer’s Disease: Advances and Perspectives in Translational Research
    Simoneide Souza Titze-de-Almeida, Clara Luna Marina, Milena Vieira Ramos, Letícia Dias dos Santos Silva, Pedro Renato de Paula Brandão, Diógenes Diego de Carvalho Bispo, Felipe von Glehn, Ricardo Titze‐de‐Almeida · 2025 · International Journal of Molecular Sciences
61. Plasma biomarkers distinguish Boston Criteria 2.0 cerebral amyloid angiopathy from healthy controls
    Ryan T. Muir, Sophie K. Stukas, Jennifer G Cooper, Andrew E. Beaudin, Cheryl R. McCreary, Myrlene Gee, Krista Nelles, Nikita Nukala, Janina Valencia, Kristopher M. Kirmess et al. · 2025 · Alzheimer s & Dementia
62. Superior Global Cognition in Oldest-Old Is Associated with Resistance to Neurodegenerative Pathologies: Results from The 90+ Study
    Roshni Biswas, Claudia H. Kawas, Thomas Jude Montine, Syed Abbas Bukhari, Luohua Jiang, María M. Corrada · 2023 · Journal of Alzheimer s Disease
63. Recent advances in understanding Alzheimer’s Disease: diagnosis and management strategies
    Anna Marín, Andrew E. Budson · 2023 · Faculty Reviews
64. Vascular risk factor associations with subjective cognitive decline and mild behavioural impairment
    Dylan X. Guan, Aditya Aundhakar, Sarah Tomaszewski Farias, Clive G. Ballard, Byron Creese, Anne Corbett, Ellie Pickering, Pamela Roach, Eric Edward Smith, Zahinoor Ismail · 2025 · Brain Communications
65. Clinicopathological correlations and cholinesterase expression in early-onset familial Alzheimer's disease with the presenilin 1 mutation, Leu235Pro
    Meghan K. Cash, Kenneth J. Rockwood, John D. Fisk, Sultan Darvesh · 2021 · Neurobiology of Aging
66. Depressive symptoms and CSF Alzheimer's disease biomarkers in relation to clinical symptom onset of mild cognitive impairment
    Carol K. Chan, Anja Soldan, Corinne A. Pettigrew, Jiangxia Wang, Marilyn Albert, Paul B. Rosenberg · 2020 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
67. Mixed Neuropathologies, Neural Motor Resilience and Target Discovery for Therapies of Late-Life Motor Impairment
    Aron S. Buchman, David Alan Bennett · 2022 · Frontiers in Human Neuroscience
68. Association of AK4 Protein From Stem Cell–Derived Neurons With Cognitive Reserve
    Lei Yu, Y. Hsieh, R. Pearse, Yan-Ling Wang, V. Petyuk, J. Schneider, A. Buchman, N. Seyfried, P. D. De Jager, Tracy L. Young-Pearse et al. · 2022 · Neurology
69. Management of Dementia
    Cynthia M. Carlsson · 2022 · CONTINUUM Lifelong Learning in Neurology
70. Vascular cognitive impairment
    Anna Nicolaevna Bogolepova · 2022 · S S Korsakov Journal of Neurology and Psychiatry
71. The comprehensive, customized, cost‐effective approach (CCCAP) to prevention of dementia
    Vladimir Hachinski, the Dementia Prevention Initiative · 2022 · Alzheimer s & Dementia
72. Parkinson Disease Neuropathological Comorbidities: Prevalences from Younger-Old to Older-Old, With Comparison to Non-Demented, Non-Parkinsonian Subjects
    Thomas G. Beach, Geidy E. Serrano, Erika D. Driver‐Dunckley, Lucia I. Sue, Holly A. Shill, Shyamal H. Mehta, Christine M. Belden, Ileana Lorenzini, Cécilia Tremblay, Parichita Choudhury et al. · 2025 · medRxiv
73. Antiplatelet therapy and incident cognitive impairment or dementia—a systematic review and meta-analysis of randomised clinical trials
    Kevin Kitt, Robert Murphy, Aoibhin Clarke, Catriona Reddin, John P. Ferguson, Jackie Bosch, William N. Whiteley, Michelle D. Canavan, Conor S. Judge, Martin James O'Donnell · 2023 · Age and Ageing
74. A novel neuroimaging signature for ADRD risk stratification in the community
    Claudia Liliana Satizábal, Alexa Beiser, Evan M. Fletcher, Sudha S. Seshadri, Charles S DeCarli · 2023 · Alzheimer s & Dementia
75. Brain and serum lipidomic profiles implicate Lands cycle acyl chain remodeling association with APOEε4 and mild cognitive impairment
    Jason A. Mares, Ana Paula Costa, William Jones Dartora, Krista Minéia Wartchow, Artur Lazarian, David Alan Bennett, Tal Nuriel, Vilas Menon, Laura Beth McIntire · 2024 · Frontiers in Aging Neuroscience
76. Comorbidities in early-onset sporadic versus presenilin-1 mutation-associated Alzheimer disease dementia: Evidence for dependency on Alzheimer disease neuropathological changes
    Diego Sepúlveda Falla, Carlos Andrés Villegas‐Lanau, Charles L. White, Geidy E. Serrano, Juliana Acosta‐Uribe, Bárbara Mejía‐Cupajita, Nelson David Villalba‐Moreno, Pinzhang Lu, Markus Glatzel, Julia Kofler et al. · 2024 · Journal of Neuropathology & Experimental Neurology
77. Precision diagnosis of cognitive impairment due to Alzheimer's disease for therapeutic interventions
    David S. Knopman · 2024 · Alzheimer s & Dementia
78. Unraveling the link between frailty and Alzheimer’s disease biomarkers in patients with mild cognitive impairment
    Simona Buscarnera, Marco Canevelli, Giuseppe Bruno, Valentina Garibotto, Giovanni Battista Frisoni, Federica Ribaldi · 2025 · GeroScience
79. Meta-analyses of personality change from the preclinical to the clinical stages of dementia
    Antonio Terracciano, Martina Luchetti, Selin Karaköse, Amanda A Miller, Yannick Stéphan, Angelina R. Sutin · 2025 · Ageing Research Reviews
80. Evaluation of Copathology and Clinical Trajectories in Individuals With Tau-Clinical Mismatch
    Christopher A. Brown, Nidhi S. Mundada, Katheryn A Q Cousins, Niyousha Sadeghpour, Xueying Lyu, Emily McGrew, Magdalena Korecka, Alice S. Chen‐Plotkin, Long Xie, Laura E.M. Wisse et al. · 2025 · JAMA Neurology
81. Predicting age at Alzheimer's dementia onset with the cognitive clock
    Lei Yu, Tianhao Wang, Robert Smith Wilson, Wensheng Guo, Neelum T. Aggarwal, David Alan Bennett, Patricia A. Boyle · 2023 · Alzheimer s & Dementia
82. Efficient identification of Alzheimer’s brain dynamics with Spatial-Temporal Autoencoder: A deep learning approach for diagnosing brain disorders
    Ling‐Yun Wu, Quanfa Zhao, Jing Liu, Haitao Yu · 2023 · Biomedical Signal Processing and Control
83. Functional dynamic network connectivity differentiates biological patterns in the Alzheimer’s disease continuum
    Pini, Lorenzo, Brusini, Lorenza, Griffa, Alessandra, Cruciani, Federica, Allali, Gilles, Frisoni, Giovanni B., Corbetta, Maurizio, Menegaz, Gloria, Boscolo Galazzo, Ilaria · 2025 · Neurobiology of Disease
84. SPARE-Tau: A flortaucipir machine-learning derived early predictor of cognitive decline
    Jon B. Toledo, Tanweer Rashid, Hangfan Liu, Lenore J. Launer, Leslie M. J. Shaw, Susan R. Heckbert, Michael Walter Weiner, Sudha S. Seshadri, Mohamad Habes, Alzheimer’s Disease Neuroimaging Initiative · 2022 · PLoS ONE
85. It is time to share Alzheimer biomarker results in dementia with Lewy bodies
    Melissa J. Armstrong, Joshua D. Grill, Thomas Francis Tropea · 2025 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
86. Global, regional, and national burden of Alzheimer’s disease and other dementias from 1990 to 2021: findings from the Global Burden of Disease Study 2021
    Yinglei Duan, Chongfang Han, Hua Zheng, Jing Hua Yu, Min Luo · 2025 · Frontiers in Aging Neuroscience
87. Optimizing Alzheimer’s Disease Therapy Using a Neural Intelligent Agent-Based Platform
    Hamdi Ben Abdessalem, Alexie Byrns, Claude Frasson · 2021 · International Journal of Intelligence Science
88. Cancer research provides a model for advancing clinical trials in dementia in the era of disease-modifying Alzheimer’s-type dementia therapies
    Gregory A. Jicha, Thomas C. Tucker, Susanne M. Arnold, Peter T. Nelson · 2024 · Alzheimer s Research & Therapy
89. Increased Risk of Dementia and its Subtypes following Various Forms of Acquired Brain Injury: a Meta-analysis and Systematic Review
    Jacob Thompson, Maryam Vasefi · 2025 · Neuroscience
90. Frailty across Neurological Diseases: Why Sex and Gender Matter
    Lorena Lorefice, Maria Teresa Pellecchia · 2025 · Annals of Neurology
91. Interaction Between Arteriosclerosis and Amyloid-β on Cognitive Function
    Ingeborg Frentz, Joyce van Arendonk, Anna Elisabeth Leeuwis, Meike Willemijn Vernooij, Wiesje M. van der Flier, Daniël Bos, Peter Paul De Deyn, Frank J. Wolters, M. Arfan Ikram · 2024 · Journal of Alzheimer s Disease
92. Cognitive decline profiles associated with lewy pathology in the context of Alzheimer’s disease neuropathologic change
    Jon B. Toledo, David P. Salmon, Melissa J. Armstrong, Douglas Galasko · 2024 · Alzheimer s Research & Therapy
93. Prediction of misfolded proteins spreading in Alzheimer’s disease using machine learning and spreading models
    Luca Gherardini, Aleksandra Zajdel, Lorenzo Pini, Alessandro Crimi · 2023 · Cerebral Cortex
94. Social relationships, amyloid burden, and dementia: The ARIC‐PET study
    Renée C. Groechel, Albert C. Liu, Chelsea Liu, David S. Knopman, Silvia Koton, Anna Kucharska‐Newton, Pamela L. Lutsey, Thomas H. Mosley, Priya Palta, A. Richey Sharrett et al. · 2024 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
95. Comorbidities in Early-Onset Sporadic versus Presenilin-1 Mutation-Associated Alzheimer’s Disease Dementia: Evidence for Dependency on Alzheimer’s Disease Neuropathological Changes
    Diego Sepúlveda Falla, Carlos Andrés Villegas‐Lanau, Charles L. White, Geidy E. Serrano, Juliana Acosta‐Uribe, Bárbara Mejía‐Cupajita, Nelson David Villalba‐Moreno, Pinzhang Lu, Markus Glatzel, Julia Kofler et al. · 2023 · medRxiv
96. Essential New Complexity-Based Themes for Patient-Centered Diagnosis and Treatment of Dementia and Predementia in Older People: Multimorbidity and Multilevel Phenomenology
    Eli Wertman · 2024 · Journal of Clinical Medicine
97. CTE neuropathology alone is associated with dementia and cognitive symptoms
    Rachael M. Layden, Jenna Rae Groh, Annalise E. Miner, Abigail Kidd, Sophia B. Nosek, Stephanie Gonzalez Gil, Bobak Abdolmohammadi, Steven Lenio, Christopher J. Nowinski, Yorghos Tripodis et al. · 2026 · Alzheimer s & Dementia
98. Differential gene expression analysis based on linear mixed model corrects false positive inflation for studying quantitative traits
    Shizhen Tang, Aron S. Buchman, Yanling Wang, Denis R. Avey, Jishu Xu, Shinya Tasaki, David A. A Bennett, Qi Zheng, Jingjing Yang · 2023 · Scientific Reports
99. CD33 and SHP-1/PTPN6 Interaction in Alzheimer’s Disease
    Lien Beckers, Mamunur Rashid, Annie Lee, Zena K. Chatila, Kirstin A. Tamucci, Ryan Talcoff, Jennifer L. Hall, David Bennett, Badri Narayan Vardarajan, Elizabeth M. Bradshaw · 2024 · Genes
100. Beta-Amyloid Related Neurodegenerative and Neurovascular Diseases: Potential Implications for Transfusion Medicine
     Ryan T. Muir, Jeannie L. Callum, Amy Yu, Moira K. Kapral, Richard H. Swartz, Sandra E. Black, Bradley J. MacIntosh, Dean A. Fergusson, Steven H Kleinman, Andrew M. Demchuk et al. · 2024 · Transfusion Medicine Reviews